|
[Logo - CDER] CHEMISTRY REVIEW TEMPLATE
[Logo - CDER] |
Chemistry Assessment Section
|
a.
Preparation................................................... .............................................................................. |
19 |
|
b.
Specifications............................................................................................................................... |
20 |
|
6. Regulatory
Specifications/Analytical Methods
.................................................................................. |
21 |
|
a. Drug
Substance Specifications & Tests
........................................................................................ |
21 |
|
b. Purity
Profile................................................................................................................................ |
21 |
|
c. Microbiology
............................................................................................................................... |
25 |
|
7. Container /
Closure System For Drug Substance Storage
.................................................................... |
26 |
|
8. Drug Substance
Stability
................................................................................................................... |
27 |
|
II. DRUG PRODUCT
................................................................................................................................ |
31 |
|
1.
Components/Composition
.................................................................................................................. |
31 |
|
2. Specifications
& Methods For Drug Product Ingredients
..................................................................... |
33 |
|
a. Active Ingredient(s)
..................................................................................................................... |
33 |
|
b. Inactive
Ingredients
..................................................................................................................... |
33 |
|
3. Manufacturer
................................................................................................................................... |
34 |
|
4. Methods of
Manufacturing and Packagingg [Packaging] ..................................................................... |
36 |
|
a. Production
Operations
................................................................................................................. |
39 |
|
b. In-Process
Controls & Tests
........................................................................................................ |
39 |
|
c. Reprocessing
Operations
............................................................................................................. |
39 |
|
5. Regulatory
Specifications and Methods For Drug Product
................................................................... |
40 |
|
a. Sampling
Procedures ................................................................................................................... |
40 |
|
b. Regulatory
Specifications And Methods
........................................................................................ |
40 |
|
6. Container/Closure
System
................................................................................................................. |
46 |
|
7. Microbiology .................................................................................................................................... |
50 |
|
8. Drug Product
Stability
....................................................................................................................... |
51 |
|
III. INVESTIGATIONAL FORMULATIONS
............................................................................................ |
57 |
|
IV. ENVIRONMENTAL ASSESSMENT ................................................................................................... |
58 |
|
V. METHODS VALIDATION
.................................................................................................................. |
58 |
|
VI. LABELING
......................................................................................................................................... |
59 |
|
VII. ESTABLISHMENT
INSPECTION ..................................................................................................... |
61 |
|
VIII. DRAFT DEFICIENCY
LETTER
........................................................................................................ |
62 |
Page 3 of 4444
Back a Page
Next Page
Back to Wellbutrin XL NDA Index Page
Back to Main Index Page